Cryoport(CYRX) - 2023 Q4 - Annual Results

Exhibit 99.1 Cryoport Reports Fourth Quarter and Full Year 2023 Financial Results "Product revenues were lower than historical levels; however, MVE Biological Solutions' revenue began to stabilize in the latter part of the year. Moreover, MVE continues to be a strong business unit, which has generated considerable free cash flow and maintained margins on its product revenue. "Throughout 2023, we made targeted investments in our business and formed strategic relationships to further position ourselves for co ...